GSK - GSK plc
57.07
-1.220 -2.138%
Share volume: 3,846,812
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$58.29
-1.22
-0.02%
Summary score
43%
Profitability
58%
Dept financing
22%
Liquidity
25%
Performance
38%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
20.76%
Return on assets
2.54%
Return on sales
20.73%
Return on invested capital
3.64%
Total debt ratio
92.49%
Debt ratio change over timeo
0%
Current Ratio
0.79%
Quick Ratio
0.54%
Cash Position Ratio
0.19%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
12.07%
Return on assets
2.1%
Return on sales
20.03%
Return on invested capital
4.27%
Total debt ratio
83.93%
Debt ratio change over timeo
0%
Current Ratio
0.88%
Quick Ratio
0.62%
Cash Position Ratio
0.23%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
8.7%
Return on assets
2.83%
Return on sales
26.47%
Return on invested capital
3.2%
Total debt ratio
82.35%
Debt ratio change over time
0%
Current Ratio
0.9%
Quick Ratio
0.61%
Cash Position Ratio
0.19%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GSK | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 20.76% | 18.71% | 4.67% | -3.65% |
| Return on assets | 2.54% | 3.4% | 3.32% | 3.5% |
| Return on sales | 20.73% | 24.27% | 25.81% | 31.31% |
| Return on invested capital | 3.64% | 5.38% | 4.17% | 4.99% |
| Profitability | 77% | 91% | 69% | 73% |
| Total debt ratio | 92.49% | 78.91% | 58.54% | 101.15% |
| Debt ratio change over time | 0% | 0% | 10.69% | 52.18% |
| Dept financing | 23% | 20% | 20% | 50% |
| Current Ratio | 0.88% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 0.62% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 0.23% | 0.21% | 0.6% | 1.41% |
| Liquididy | 30% | 53% | 70% | 73% |
| Short-term ratios | GSK | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 12.07% | 41.05% | 6.87% | -16.17% |
| Return on assets | 2.1% | 3.67% | 3.13% | 2.71% |
| Return on sales | 20.03% | 26.16% | 24.75% | 29.9% |
| Return on invested capital | 4.27% | 9.43% | 5.58% | 6.54% |
| Profitability | 50% | 97% | 61% | 61% |
| Total debt ratio | 83.93% | 91.28% | 61.3% | 99.31% |
| Debt ratio change over time | 0% | 0% | 13.89% | -24.55% |
| Dept financing | 21% | 23% | 40% | 25% |
| Current Ratio | 0.88% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 0.62% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 0.23% | 0.21% | 0.6% | 1.41% |
| Liquididy | 23% | 31% | 41% | 75% |